Results

Total Results: 463 records

Showing results for "renal".

41. Calcineurin Inhibitors for Kidney Transplant | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research
    March 15, 2016 - English-language studies of adult renal transplants were included. … Moderate-strength evidence suggests that renal function is better in patients receiving sirolimus or … Many studies suggest that early initiation of low-dose CNIs results in improved renal function and reduced … conversion from CNIs to mTOR (mammalian target of rapamycin) inhibitors are associated with improved renal … Regimens that withdraw CNIs are not associated with improved renal function and may increase the risk

42. Microsoft Word - finapps.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
    January 01, 2007 - / 2 exp Renal Artery Obstruction/ 3 renal arter$ stenosis.tw. 4 renal arter$ dis$.tw. 5 renovascular … Diagnosis and outcome of renal function in patients with renal artery stenosis: which role have color … The management of renal artery atherosclerosis for renal salvage: does stenting help? … renal Fractional Flow Reserve. … Stenting of renal artery stenosis: is it beneficial in chronic renal failure?

43. Microsoft Word - finbody.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - We combined search terms for renal artery stenosis, renal hypertension, and renal vascular disease, … with renal artery stenosis? … renal failure. … Effect of renal-artery stenting on progression of renovascular renal failure. … Stenting of renal artery stenosis: is it beneficial in chronic renal failure?

44. Vascular Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
    August 16, 2010 - Research Protocol Archived May 17, 2013 Troponin Cardiac Marker Interpretation During Renal … Optimal Second-Line Therapy for Hypertension Abstract Archived January 1, 2005 Renal … Artery Stenosis Update Research Protocol Archived January 20, 2015 Renal Artery … Archived December 8, 2010 Comparative Effectiveness of Management Strategies for Renal … Archived November 19, 2007 Comparative Effectiveness of Management Strategies for Renal

45. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0309_05-03-2008.pdf
    January 01, 2008 - 1 Results of Topic Selection Process & Next Steps  Management of patients with mild renal … association Nomination Summary: The nominator is interested in the management of patients with mild renal … What is most useful clinical typology of mild renal impairment (e.g., with and without proteinuria, … with or without renal tubular acidosis, etc.)? … Management of Patients with Mild Renal Impairment Nomination Summary Document https://subscriptions.ahrq.gov

46. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - The leading theories are that CIN results from hypoxic injury of the renal tubules induced by renal … to moderate renal insufficiency: a double-blind, randomized clinical trial. … Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and … Comparing the renal safety of isoosmolar versus low-osmolar contrast medium by renal biomarkers N-acetyl-beta-D-glucosaminidase … Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999 Jul;72(859):701-3.

47. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
    January 01, 2007 - Layout 1 This report is an update to a Comparative Effectiveness Review on management strategies for renal … This report does not address the management of fibromuscular dysplasia, renal transplant recipients, … For patients with atherosclerotic renal artery stenosis in the modern management era (i.e., since JNC … on the effects of aggressive medical therapy Comparative Effectiveness of Management Strategies for Renal … Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: 2007 Update.

48. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0496_12-30-2011.pdf
    January 01, 2011 - Description Nominator: Individual Nomination Summary: The nominator questions the comparative renal … diagnostic procedures requiring the use of contrast media; subgroups of interest include patients with renal … methods, pharmacologic strategies (e.g., Fenoldpam, Mannitol, Theophylline, natriuretic peptides), and renal … biochemical evidence of organ function (serum creatinine or creatinine clearance), mortality, rate of renal … What is the comparative renal safety of different contrast media used in radiographic imaging?

49. Prevention of Contrast Media Induced Nephropathy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/nephropathy-contrast-induced/research-protocol
    November 12, 2013 - Objectives for the Systematic Review Contrast induced nephropathy (CIN) is defined as impairment of renal … function measures Development of CIN as defined by change in creatinine or change in GFR Renal … disease; KQ=Key question; RRT=renal replacement therapy Figure 1b. … disease; KQ=Key question; RRT=renal replacement therapy Methods A. … In 1% of all patients undergoing contrast enhanced CT the decline in renal function persisted.

50. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/1-does-mass-spectrometric-analysis-and-therapeutic-monitoring-of-tacrolimus-as-compared-with-immunoassay-analysis-and-therapeutic-monitoring-produce-a-better-organ-survival-rate-b-fewer-rejections-c-less-nephrotoxicity-andor-
    September 14, 2012 - better organ survival rate, b) fewer rejections, c) less nephrotoxicity and/or d) cost savings in renal … better organ survival rate, b) fewer rejections, c) less nephrotoxicity, and/or d) cost savings in renal … organ survival rate, b) fewer rejection episodes, c) less nephrotoxicity,and/or d) cost savings in renal … adult renal patients Are there subgroups of patients that your question might apply to? … In addition, 31% of deaths in renal transplant patients were deaths with a functioning graft from co

51. Treatment for Acute Pain: An Evidence Map | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/acute-pain-treatment/technical-brief
    October 22, 2019 - for several acute pain conditions including postoperative pain, dental pain, neck pain, back pain, renal … overview of systematic reviews include postoperative postdischarge pain, acute back pain, acute neck pain, renal … warrant a new systematic review: pain associated with dental procedures and oral surgery, low back pain, renal … pain conditions (postdischarge postoperative pain, musculoskeletal pain, acute migraine, dental pain, renal

52. Troponin cardiac marker interpretation during renal function impairment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/troponin-cardiac-marker-interpretation-during-renal-function-impairment
    June 17, 2008 - Troponin cardiac marker interpretation during renal function impairment Cardiac Troponins Used

53. The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
    August 27, 2012 - toxicity, Efficacy, Weight of evidence, Renal toxicity Mean relative importance German … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Slide 16 Maximum Acceptable Risk Calculation Renal Cell Carcinoma Image: Bar chart showing 3 month … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal

54. Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
    March 31, 2011 - Chronic renal disease affects more than 26 million Americans and is the cause of significant morbidity … , a common complication, conveys significant risk for cardiovascular disease, faster progression of renal … In fact, most patients with chronic renal disease become anemic. … Thereby, modalities became available for the treatment of anemia in chronic renal failure, chemotherapy-treated

55. Kidney-Disease-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
    January 01, 2012 - However, these renal endpoints are not clinical outcomes. … United States Renal Data System. … Renal Disease in the United States. … Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. … Renal Association.

56. Slide 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
    August 27, 2012 - Most important Least important German patients Renal toxicity Weight of … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … RTI International Research Triangle Institute Maximum Acceptable Risk Calculation Renal Cell Carcinoma … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal … Patients rank toxicity against progression-free survival in second-line treatment of advanced renal

57. Data-Points 1 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Diabetes Rate in Enrolled Population Total All 2006 32.8 8.7 26.4% Age Disabled/end stage renal … Indian/Alaska Native 2006 0.1 0.1 36.0% Total All 2007 32.3 8.8 27.3% Age Disabled/end stage renal … Indian/Alaska Native 2007 0.2 0.1 37.3% Total All 2008 31.9 8.9 27.9% Age Disabled/end stage renal … Indian/Alaska Native 2006 9.7% 28.4% 6.4% Total All 2007 8.1% 18.9% 5.0% Age Disabled/end stage renal … of Major and Minor LEA in the Same Year Total All 2006 1.4% 0.5% 0.3% Age Disabled/end stage renal

58. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/sodium-potassium/research-protocol
    March 01, 2017 - lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR (( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR

59. Effects of Dietary Sodium and Potassium Intake on Chronic Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
    April 18, 2017 - lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR acute kidney injur* … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND humans[MESH] OR ( … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi AND "Prospective Studies … lithiasis OR nephrolith* OR nephrolithiasis OR renal stone OR renal calculi OR "Mortality"[Mesh] OR

60. Data-Points 2 Diabetic-Foot-Ulcers Data 02-2011 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Beneficiaries With Diabetes and Without PAD Total All 2006 6.0% 13.5% 4.0% Age Disabled/end stage renal … Indian/Alaska Native 2006 6.9% 17.9% 5.0% Total All 2007 6.0% 13.2% 4.0% Age Disabled/end stage renal … /Alaska Native 2006 1.0% 5.6% 0.135% Total All 2007 0.5% 1.9% 0.055% Age Disabled/end stage renal … /Alaska Native 2007 0.8% 4.7% 0.131% Total All 2008 0.4% 1.8% 0.058% Age Disabled/end stage renal … Diabetic Population Q1 Q2 Q3 Q4 Total All 2006 0.18% 0.14% 0.12% 0.12% Age Disabled/end stage renal